BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• 

  CRISPR

  Ongoing CRISPR Patent Dispute Complicates Licensing but Hasn’t Deterred Gene-Editing Investment

  As the yearslong litigation over ownership of CRISPR gene editing continues, investors have forged ahead with funding the technology’s development by biopharma.

  July 17, 2024

   · 

  8 min read

   · 

  Christoph Schwaiger
• Press Releases

  FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products

  July 17, 2024

   · 

  4 min read
• Press Releases

  Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - July 16, 2024

  July 17, 2024

   · 

  1 min read
• Press Releases

  Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

  July 17, 2024

   · 

  4 min read
• Press Releases

  Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million

  July 17, 2024

   · 

  4 min read
• Press Releases

  Endo USA, Inc. Issues Voluntary, Nationwide Recall of One Lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Lot Number 550147301 Due to Mislabeling: Incorrect Strength on Product Carton

  July 17, 2024

   · 

  5 min read
• Press Releases

  FDA Roundup: July 16, 2024

  July 17, 2024

   · 

  4 min read
• 

  Podcast

  Pfizer’s Oral GLP-1 Push, Lilly Vs. Novo and PBMs Under Pressure

  Pfizer selects its candidate for the oral GLP-1 race as Eli Lilly strives to overtake Novo Nordisk in the injectable weight-loss drug space. Meanwhile, pressure builds to reduce drug prices in the U.S.

  July 17, 2024

   · 

  1 min read

   · 

  Heather McKenzie
• Press Releases

  GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities

  July 17, 2024

   · 

  3 min read
• Press Releases

  [Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity

  July 17, 2024

   · 

  9 min read